The Merck Family
Did you know there’s a family so wealthy they’ve been running a successful business for over 350 years? The Merck family, a German dynasty, has not only survived wars and controversies but has also thrived across 13 generations. Today, the family descendants still own 70% of Merck KGaA, a pharmaceutical giant with an estimated net worth of $80 billion. Currently, 204 family members share in the company’s wealth, but only a select few are involved in its management. Unlike many family-run businesses that struggle to maintain control, Merck operates with strict rules: family members must prove their skills in another career before being allowed to join the business, and they can never sell their shares!
Their company has revolutionized medicine with life-saving drugs and vaccines but has also been involved in some pretty dark stuff. Now, let me tell you their incredible success story, filled with secrets, scandals, and even a bit of family drama.
The History of Merck – World’s Oldest Pharmaceutical Company
The story of Merck begins in 1668 in Darmstadt, Germany, when Friedrich Jacob Merck, a 20-year-old apprentice pharmacist with big ambitions, acquired a small pharmacy named the Engel Apotheke or Angel Pharmacy.
Before Friedrich’s acquisition, the pharmacy had an interesting backstory. It was established by a court pharmacist named Samuel Bockler, who had received permission from the Landgrave of Hesse-Darmstadt to open Darmstadt’s second public pharmacy. The Angel Pharmacy quickly became a trusted establishment in Darmstadt, offering remedies and herbal medicines crafted using traditional methods. And when Friedrich acquired it, he likely had no idea that this small pharmacy would be the seed of a family empire that would eventually span centuries and continents.
At that time, medicine was a blend of science and guesswork. Pharmacists relied on natural ingredients and rudimentary formulations, as recorded in texts like The Pharmacopoeia Augustana. Despite the lack of precise standards, Friedrich Merck worked diligently to establish a trusted reputation in the local community.
After Friedrich’s passing in 1678, his nephew Georg Friedrich Merck took the reins. By 1682, the family had secured the right to keep the business running, and the pharmacy flourished as regulations for medicines and pharmacies became stricter.
A major change happened in 1816 when Emmanuel Merck, a descendant of Friedrich, took over the family pharmacy. He was both a brilliant scientist and a smart businessman. At that time, the main ingredients in medicines were alkaloids, which are plant extracts. Pharmacists would extract these substances themselves, but the quality of the products was often uneven. Emmanuel Merck developed new methods to make the extraction process more consistent and efficient. He figured out how to produce alkaloids on a much larger scale, which allowed for high-quality products.
In 1827, he began offering 48 different alkaloids to pharmacists all over Germany, promising the best quality and purity. This move turned Merck into an industrial company that made both pharmaceuticals and chemicals. People started trusting the brand, and the business grew quickly.
By 1850, Emmanuel’s three sons—Carl, Georg, and Wilhelm—had joined him in the family business.
They were well-educated in chemistry, pharmacy, and business and helped expand the company internationally. Merck opened new locations in London (1883), New York (1887), and Moscow (1899), and family members even traveled to places like Mexico, Japan, and China to sell their products.
In 1904, the company moved its operations to a larger site on the outskirts of Darmstadt and built a new factory. This expansion allowed Merck to start making readymade medicines, including pills and ointments, and soon, they had a portfolio of around 10,000 different products.
But the journey wasn’t always smooth. Two world wars brought significant challenges. During World War I, Merck lost its American subsidiary, which became an independent company, Merck & Co. The wars also disrupted operations in Germany, but the family never gave up. By the 1920s, they patented vitamins and other medicines that changed lives. One of their most notable achievements was creating a vitamin D product to combat rickets, a common disease among children at the time.
World War II brought more hardships. Bombings destroyed much of the company’s facilities, and many employees were conscripted into the military. Women stepped in to keep operations running, and by 1947, Merck had resumed exporting its products worldwide.
Merck’s innovations didn’t stop there. In the mid-20th century, the company developed life-saving drugs for heart disease and diabetes. And you know what? They also played a role in space exploration! When astronauts from Apollo 11 walked on the moon in 1969, they carried Merck’s decongestant medicine to help with nasal swelling caused by weightlessness.
In the years that followed, Merck kept growing, making medicines for cancer, diabetes, and even vaccines to solve some of the world’s most challenging health problems.
What’s the SECRET behind this 350-year-old success story?
The Merck family has a unique approach to running their 350-year-old business. They believe in teaching and preparing each generation, ensuring that the family legacy continues with care and responsibility. To help with this, they’ve set up special programs and events to educate family members about the company, its values, and how to be good leaders.
One of their key tools is the Merck Family University. They select a small group of family members every five years for an intensive program. Participants learn about leadership, business strategies, and family dynamics. Top professors and company experts guide them through lessons to ensure they understand Merck’s business and the importance of teamwork within the family.
The family also organizes an annual event called Merck Family Day. It’s a time when family members of all ages come together, share ideas, and learn about the company’s recent achievements. This event helps younger members connect to the company’s history while bonding with their relatives.
Family members are encouraged to get involved from a young age. Programs like “Merck Next Generation” teach teenagers and young adults about business and family governance. They also visit factories around the world to see the company’s operations firsthand.
However, being part of the Merck family doesn’t mean you automatically get a job in the business. Everyone must meet high standards, which include getting a good education, gaining work experience outside the company, and proving they have the skills to lead.
The Merck family believes in modesty and long-term thinking. They avoid showing off wealth and focus on making decisions that benefit the company and the family for future generations. By staying connected and prioritizing education, they’ve managed to keep their family united while growing a global business that’s over 13 generations strong.
Did the Merck family members ever fight over control of their Multi-Billion-Dollar empire?
Unlike many family-run businesses that struggle to maintain control, the Merck family has implemented robust governance structures to maintain unity and prevent conflicts within the family. The family established a “Family Constitution” in 1888, which is regularly updated and serves as a guiding document for family members. This constitution outlines the separation of ownership and management, roles and responsibilities, and shared objectives, helping to minimize potential conflicts over strategy, money, status, and authority. Their governance structure ensures only the best and most qualified carry the family torch forward.
Due to these strong governance practices, Merck has thrived and expanded globally. Today, the company generates an annual revenue of 20 billion euros and operates with a workforce of nearly 62,000 employees spread across 68 countries.
However, the family’s strict governance rules, under which new members must prove themselves through external careers before joining the business, occasionally breed resentment or feelings of exclusion among less involved relatives, adding to the drama behind closed doors.
Controversies and Scandals
Merck’s family business has faced several controversies over the years. In the 1970s, Merck was among several drug producers sued by women who claimed they had vaginal cancer and other health problems because their mothers had used the drug diethylstilbestrol (DES) during pregnancy. Despite evidence that DES caused cancer in animals, the drug had been widely prescribed to prevent miscarriages.
The most significant controversy occurred in the early 2000s with the arthritis drug Vioxx. Initially marketed as a safer alternative to traditional painkillers, Vioxx was linked to an increased risk of heart attack and stroke. In 2004, Merck withdrew Vioxx from the market after studies revealed these severe side effects. The company later agreed to pay billions of dollars to resolve thousands of lawsuits related to its promotion and marketing of Vioxx.
In 2024, Merck faced new challenges with its asthma medication, Singulair. U.S. government researchers found that Singulair may be linked to serious mental health problems for some patients. The FDA added a “black box” warning to the prescribing label, highlighting risks like suicidal thinking or actions. These events have raised concerns about Merck’s practices and their impact on public health and trust.
However, the Merck family’s dedication to excellence and long-term vision have kept the company at the forefront of the industry. Today, Merck continues to shape the future of medicine, proving that while family dynamics can be complex, a strong legacy and commitment to progress can overcome even the most dramatic challenges.
Author